Evotaz (atazanavir 300mg and cobicistat 150mg) tablets are approved for use in combination with other antiretroviral agents to treat HIV-1 infected adults without known mutations associated with resistance
Currently, benralizumab is in Phase III development for the treatment of severe uncontrolled asthma and COPD. Benralizumab targets the IL-5 receptor and reduces eosinophils, which play a major
Under the deal, Celgene will pay $232 per share in cash for Receptos, which is focused on developing therapeutic candidates for the treatment of immune and metabolic diseases.
The company markets Nyloxin and Pet Pain-Away in the over-the-counter (OTC) pain management market, and also develops treatments for multiple sclerosis (MS), HIV, adrenomyeloneuropathy (AMN) and pain. The
The company develops a proprietary platform for the sustained production and delivery of therapeutic proteins and peptides in patients using ex vivo gene therapy and their own tissue
The company noted that this orphan designation is valid for all applications of DPX-Survivac in ovarian cancer without restriction to a specific stage of disease. DPX-Survivac activates and
APG101 is a fully-human fusion protein that inhibits the CD95 ligand, a member of the tumor necrosis factor (TNF) family. It isindicated to treat glioblastoma multiforme in China,
As part of the deal, Laboratorios Saval will be responsible to secure regulatory and pricing approval as well as provide marketing and distribution of the product in Bolivia,
As part of the deal, both the parties will carry out studies designed to improve the mechanistic understanding of fibrosis, explore patient segmentation based on disease characteristics and/or
Rett syndrome primarily affects females with an estimated prevalence ranging from one in 10,000 to 20,000 females and there are no approved treatments available. In preclinical testing with
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.